Literature DB >> 24412633

Kidney cancer cells secrete IL-8 to activate Akt and promote migration of mesenchymal stem cells.

Liang-kuan Bi1, Nan Zhou2, Cheng Liu1, Fu-Ding Lu1, Tian-Xin Lin1, Xu-Jun Xuan1, Chun Jiang1, Jin-Li Han1, Hai Huang1, Cai-Xia Zhang1, Wen Dong1, Hao Liu1, Jian Huang1, Ke-Wei Xu3.   

Abstract

BACKGROUND: Mesenchymal stem cells (MSCs) are multipotent adult stem cells that have the capability of homing to cancer cells. Thus, MSCs play an important role in the development, metastasis, and drug resistance of cancers. The mechanisms underlying the homing of MSCs in kidney cancer are still poorly understood.
METHODS: In the present study, enzyme-linked immunosorbent assay was used to measure the level of IL-8 in patients with kidney cancer and in the culture medium of kidney cancer cells. Immunofluorescence staining and reverse transcription polymerase chain reaction were utilized to explore the main receptor for IL-8 in MSCs. Transwell migration assay was performed to measure the migration ability of MSCs and Western blot test was performed to test the activation of signaling pathways.
RESULTS: The serum level of IL-8 was markedly increased in patients with kidney cancer, and 2 kidney cancer cell lines were found to secrete IL-8. MSCs had high expression of the IL-8 receptor (CXCR2). Blocking IL-8 or CXCR2 could decrease the migration ability of MSCs. IL-8 could significantly increase Akt phosphorylation in MSCs.
CONCLUSIONS: Kidney cancer cells secrete IL-8 to activate the Akt signaling pathway via CXCR2 on MSCs, inducing the migration of MSCs, which may be one of the important mechanisms underlying the homing of MSCs in kidney cancer.
© 2013 Published by Elsevier Inc.

Entities:  

Keywords:  Akt; Extracellular signal-regulated protein kinase; Interleukin-8; Kidney cancer; Mesenchymal stem cell

Mesh:

Substances:

Year:  2014        PMID: 24412633     DOI: 10.1016/j.urolonc.2013.10.018

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  12 in total

Review 1.  Mesenchymal Stem Cell Transplantation for Ischemic Diseases: Mechanisms and Challenges.

Authors:  Thi-Tuong Van Nguyen; Ngoc Bich Vu; Phuc Van Pham
Journal:  Tissue Eng Regen Med       Date:  2021-04-21       Impact factor: 4.169

2.  Carcinogenic activity of PbS quantum dots screened using exosomal biomarkers secreted from HEK293 cells.

Authors:  Jung-Hee Kim; Hye-Rim Kim; Bo-Ram Lee; Eun-Sook Choi; Su-Il In; Eunjoo Kim
Journal:  Int J Nanomedicine       Date:  2015-08-31

3.  Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8.

Authors:  Wei Li; Ying Zhou; Jin Yang; Xu Zhang; Huanhuan Zhang; Ting Zhang; Shaolin Zhao; Ping Zheng; Juan Huo; Huiyi Wu
Journal:  J Exp Clin Cancer Res       Date:  2015-05-20

Review 4.  The role of chemoattractant receptors in shaping the tumor microenvironment.

Authors:  Jiamin Zhou; Yi Xiang; Teizo Yoshimura; Keqiang Chen; Wanghua Gong; Jian Huang; Ye Zhou; Xiaohong Yao; Xiuwu Bian; Ji Ming Wang
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

5.  Study on chemotaxis and chemokinesis of bone marrow-derived mesenchymal stem cells in hydrogel-based 3D microfluidic devices.

Authors:  Dayoung Yoon; Hyerim Kim; Eojin Lee; Min Hee Park; Seok Chung; Hojeong Jeon; Cheol-Hee Ahn; Kangwon Lee
Journal:  Biomater Res       Date:  2016-08-02

6.  Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.

Authors:  Zhenfeng Guan; Chong Li; Jinhai Fan; Dalin He; Lei Li
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

7.  Jolkinolide A and Jolkinolide B Inhibit Proliferation of A549 Cells and Activity of Human Umbilical Vein Endothelial Cells.

Authors:  Lei Shen; Shan-Qiang Zhang; Lei Liu; Yu Sun; Yu-Xuan Wu; Li-Ping Xie; Ji-Cheng Liu
Journal:  Med Sci Monit       Date:  2017-01-14

8.  Aspirin enhances the cytotoxic activity of bortezomib against myeloma cells via suppression of Bcl-2, survivin and phosphorylation of AKT.

Authors:  Jiang-Hua Ding; Li-Ya Yuan; Guo-An Chen
Journal:  Oncol Lett       Date:  2016-12-08       Impact factor: 2.967

Review 9.  Dissecting the role of bone marrow stromal cells on bone metastases.

Authors:  Denise Buenrostro; Serk In Park; Julie A Sterling
Journal:  Biomed Res Int       Date:  2014-06-26       Impact factor: 3.411

Review 10.  The CXCL8-CXCR1/2 pathways in cancer.

Authors:  Qian Liu; Anping Li; Yijun Tian; Jennifer D Wu; Yu Liu; Tengfei Li; Yuan Chen; Xinwei Han; Kongming Wu
Journal:  Cytokine Growth Factor Rev       Date:  2016-08-25       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.